Recent studies of psychedelic therapy, using substances like psilocybin and lysergic acid diethylamide, or LSD, show rapid and lasting improvements to conditions like depression and addiction.
Jamie Peters, Ph.D., associate professor in the Department of Neurobiology, and a team of researchers are studying a safer, more targeted version of these substances.